
    
      Bio-Equivalence study with a clinical endpoint in the treatment of acne vulgaris comparing
      adapalene cream, 0.1% test product versus the reference listed drug (RLD) and placebo
      (vehicle) control, each administered as one application once a day in the evening for 12
      weeks
    
  